| Brand Name | Entyvio (Subcutaneous) |
| Generic Name | Vedolizumab |
| Drug Class | Integrin Receptor Antagonist |
| Availability | Prescription |
| Manufacturer | Takeda Pharmaceuticals |
| Indications | Ulcerative Colitis, Crohn's Disease |
| Type | IV Infusion |
| Doses | Initial: 300 mg at weeks 0, 2, and 6, then every 8 weeks for maintenance |
| Route | SC Injection |
| Side Effects | Headache, constipation, fatigue |
| Interactions | Monoclonal antibody; avoid with live vaccines; risk of infections |
| Overdose | Headache, infections. |
| Missed Dose | Infusion-based; reschedule ASAP. |
| Contraindications | Active infections, PML risk |
| Alternatives | Upadacitinib, Filgotinib |
| Co-Pay Assistance Program | Not available |
| Patient Assistance Program | Available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
The Crohn disease of the inflammatory bowel disease and the ulcerative colitis are treated through lowering inflammation of the gastrointestinal tract by the use of Vedolizumab.
Vedolizumab is an integrin receptor entry blocker and entry inhibitor that assist the immune cells to gain entry into the inflamed sections of the bowels and blocks the inflammation.
The likely side effects include headache, joint pains, upper respiratory infections are some of them. There are extreme but deviant adverse reactions which can be allergies or liver complications.
Vedolizumab is a health care substance that is administered through intravenous (IV) administration by a medical professional. The administration route falls under the treatment disorder.
In the situation with pregnancy, Vedolizumab must be prescribed in compliance with more advantages than disadvantages. Inquiries regarding pregnancy or pregnancy of your physician.
Vedolizumab can interact with other medications, particularly the ones that impact the immune system. Never forget to report to your medical practitioner about the drugs that you take.
Also, you will have to get in touch with your physician in case you fail to take Vedolizumab. Enhance not thyself The drug.
Vedolizumab assists in disarranging a group of immune cells within the intestines alleviating the swellings and enhancing the statuses of the affected patients with the disorders of Crohn and ulcerative colitis 1 2.
That is factual that Vedolizumab will result in depressed immunity, and consequently, the elevated rates of infections. Your medical professional will note infections.
It may take weeks, months before Vedolizumab achieves all the preferred results in the treatment of such inflammatory bowel diseases as Crohn and ulcerative colitis.
Related Conditions |
Related Blogs |
|---|---|
